Company / Operating Income per Share
Unicycive Therapeutics, Inc. Operating Income per Share History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.60
FY2024
5-year range
-$1.19 / -$0.60
FY2022-FY2024
Trend
+49.6%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-0.60 in FY2024.
Remained stable around $-0.60 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, operating income per share increased 49.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.60 | +49.6% |
| FY2023 | -$1.19 | -98.0% |
| FY2022 | -$0.60 | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026